What’s The Plan? US FDA Drug Development Tool Qualification Process Requires “Cultural Change”

 
• By Michael McCaughan
  
Binoculars hang on a wooden fence background
Sponsors and the US FDA are going to need to change the way they look at biomarker development.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D